Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil

被引:41
作者
Bittencourt, PL
Palácios, SA
Cançado, ELR
Porta, G
Carrilho, FJ
Laudanna, AA
Kalil, J
Goldberg, AC
机构
[1] Portuguese Hosp Salvador, Salvador, Brazil
[2] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil
[3] Univ Sao Paulo, Sch Med, Childrens Inst, Liver Unit,Lab Immunol,Heart Inst, Sao Paulo, Brazil
关键词
D O I
10.1016/S0002-9270(03)00307-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: Susceptibility to autoimmune hepatitis (AIH) has been linked to different HLA-DR antigens in distinct populations. Recently, an A-G polymorphism in exon 1 of the cytotoxic T lymphocyte antigen-4 (CTLA-4) gene was associated with predisposition to AIH type 1 (AIH-1) in white individuals in North America. This polymorphism has been associated with several other autoimmune diseases, presumably because of its effect in the expression of CTLA-4, an adhesion molecule that downregulates peripheral T cell responses. The aims of this study were to assess the frequency of CTLA-4 genotypes in Brazilian patients with AIH-1 and AIH type 2 (AIH-1), as well as to investigate the influence of these genotypes in disease expression. METHODS: Determination of CTLA-4 genotypes was carried out in 106 patients with AIH-1, 26 subjects with AIH-2, and 67 healthy control subjects by polymerase chain reaction (PCR)-based techniques. RESULTS: No difference in the distribution of CTLA-4 genotypes was observed in subjects with AIH-1 and AIH-2 as compared to healthy controls. Patients with AIH-1 and AIH-2 with the GG genotype exhibited lower gamma-globulin and ALT levels, respectively. CONCLUSIONS: Susceptibility to AIH-1 and AIH-2 in Brazilian patients is not influenced by exon 1 CTLA-4 gene polymorphisms at position 49. (C) 2003 by Am. Coll. of Gastroenterology.
引用
收藏
页码:1616 / 1620
页数:5
相关论文
共 30 条
[1]   CHARACTERIZATION OF THE LIVER CYTOSOL ANTIGEN TYPE-1 REACTING WITH AUTOANTIBODIES IN CHRONIC ACTIVE HEPATITIS [J].
ABUAF, N ;
JOHANET, C ;
CHRETIEN, P ;
MARTINI, E ;
SOULIER, E ;
LAPERCHE, S ;
HOMBERG, JC .
HEPATOLOGY, 1992, 16 (04) :892-898
[2]   Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis [J].
Agarwal, K ;
Czaja, AJ ;
Jones, DEJ ;
Donaldson, PT .
HEPATOLOGY, 2000, 31 (01) :49-53
[3]   International Autoimmune Hepatitis Group Report:: review of criteria for diagnosis of autoimmune hepatitis [J].
Alvarez, E ;
Berg, PA ;
Bianchi, FB ;
Bianchi, L ;
Burroughs, AK ;
Cancado, EL ;
Chapman, RW ;
Cooksley, WGE ;
Czaja, AJ ;
Desmet, VJ ;
Donaldson, RT ;
Eddleston, ALWF ;
Fainboim, L ;
Heathcote, J ;
Homberg, JC ;
Hoofnagle, JH ;
Kakumu, S ;
Krawitt, EL ;
Mackay, IR ;
MacSween, RNM ;
Maddrey, WC ;
Manns, MP ;
McFarlane, IG ;
zum Büschenfelde, KHM ;
Mieli-Vergani, G ;
Nakanuma, Y ;
Nishioka, M ;
Penner, E ;
Porta, G ;
Portmann, BC ;
Reed, WD ;
Rodes, J ;
Schalm, SW ;
Scheuer, PJ ;
Schrumpf, E ;
Seki, T ;
Toda, G ;
Tsuji, T ;
Tygstrup, N ;
Vergani, D ;
Zeniya, M .
JOURNAL OF HEPATOLOGY, 1999, 31 (05) :929-938
[4]   ANTI LIVER-KIDNEY MICROSOME ANTIBODY RECOGNIZES A 50,000 MOLECULAR-WEIGHT PROTEIN OF THE ENDOPLASMIC-RETICULUM [J].
ALVAREZ, F ;
BERNARD, O ;
HOMBERG, JC ;
KREIBICH, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (05) :1231-1236
[5]   Different HLA profiles confer susceptibility to autoimmune hepatitis type 1 and 2 [J].
Bittencourt, PL ;
Goldberg, AC ;
Cançado, ELR ;
Porta, G ;
Laudanna, AA ;
Kalil, J .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (08) :1394-1395
[6]  
Bittencourt PL, 1999, AM J GASTROENTEROL, V94, P1906
[7]   Autoimmune hepatitis in Brazilian patients is not linked to tumor necrosis factor α polymorphisms at position-308 [J].
Bittencourt, PL ;
Palácios, SA ;
Cançado, ELR ;
Porta, G ;
Drigo, S ;
Carrilho, FJ ;
Laudanna, AA ;
Kalil, J ;
Goldberg, AC .
JOURNAL OF HEPATOLOGY, 2001, 35 (01) :24-28
[8]  
Cancado ELR, 1996, HEPATOLOGY, V23, P1098
[9]   The expanding world of co-stimulation: the two-signal model revisited [J].
Chambers, CA .
TRENDS IN IMMUNOLOGY, 2001, 22 (04) :217-223
[10]  
CORDONERFRANCH P, 1989, CLIN EXP IMMUNOL, V75, P354